Biggest News Aggregation in the World
📰 Alanr Meyer News

Alanr Meyer News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Alanr Meyer. Real-time updates on events, politics, business and more.

Ocuphire Pharma, Inc. (NASDAQ:OCUP) Sees Large Decrease in Short Interest

Ocuphire Pharma, Inc. (NASDAQ:OCUP – Get Rating) was the target of a significant decline in short interest in the month of May. As of May 31st, there was short interest totalling 1,540,000 shares, a decline of 24.5% from the May 15th total of 2,040,000 shares. Based on an average trading volume of 374,900 shares, the […]
Ocuphire Pharma Alanr Meyer Mina Patel Soouch Legato Capital Management Kestra Private Wealth Services Lincoln National Corp

Ocuphire Pharma (NASDAQ:OCUP) Trading Down 5.1%

Ocuphire Pharma, Inc. (NASDAQ:OCUP – Get Rating)’s stock price dropped 5.1% during trading on Friday . The company traded as low as $3.76 and last traded at $3.76. Approximately 163,080 shares were traded during trading, a decline of 41% from the average daily volume of 274,287 shares. The stock had previously closed at $3.96. Wall […]
Mina Patel Soouch Alanr Meyer Ocuphire Pharma Lincoln National Corp Legato Capital Management Kestra Private Wealth Services

Ocuphire Pharma, Inc. (NASDAQ:OCUP) Forecasted to Earn FY2023 Earnings of ($0.69) Per Share

Ocuphire Pharma, Inc. (NASDAQ:OCUP – Get Rating) – Analysts at Cantor Fitzgerald decreased their FY2023 earnings per share estimates for shares of Ocuphire Pharma in a report issued on Tuesday, May 16th. Cantor Fitzgerald analyst K. Kluska now expects that the company will post earnings of ($0.69) per share for the year, down from their […]
Ocuphire Pharma Mina Patel Soouch Cantor Fitzgerald Alanr Meyer Kestra Private Wealth Services Renaissance Technologies

Lincoln National Corp Makes New Investment in Ocuphire Pharma, Inc. (NASDAQ:OCUP)

Lincoln National Corp purchased a new position in shares of Ocuphire Pharma, Inc. (NASDAQ:OCUP – Get Rating) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 11,600 shares of the company’s stock, valued at approximately $41,000. Lincoln National Corp […]
Mina Patel Soouch Ocuphire Pharma Alanr Meyer Exchange Commission Renaissance Technologies Richmond Brothers Inc

Short Interest in Ocuphire Pharma, Inc. (NASDAQ:OCUP) Declines By 25.5%

Ocuphire Pharma, Inc. (NASDAQ:OCUP – Get Rating) was the recipient of a significant drop in short interest in March. As of March 31st, there was short interest totalling 675,000 shares, a drop of 25.5% from the March 15th total of 906,400 shares. Based on an average daily volume of 161,500 shares, the days-to-cover ratio is […]
Ocuphire Pharma Mina Patel Soouch Alanr Meyer Dimensional Fund Advisors Kestra Private Wealth Services Ocuphire Pharma Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Ocuphire Pharma, Inc. (NASDAQ:OCUP) Forecasted to Earn FY2023 Earnings of $0.17 Per Share

Ocuphire Pharma, Inc. (NASDAQ:OCUP – Get Rating) – Analysts at Cantor Fitzgerald lifted their FY2023 earnings per share estimates for shares of Ocuphire Pharma in a note issued to investors on Monday, April 3rd. Cantor Fitzgerald analyst K. Kluska now forecasts that the company will post earnings of $0.17 per share for the year, up […]
Cantor Fitzgerald Mina Patel Soouch Ocuphire Pharma Alanr Meyer Lincoln National Corp Geode Capital Management

Brokers Set Expectations for Ocuphire Pharma, Inc.'s Q1 2023 Earnings (NASDAQ:OCUP)

Ocuphire Pharma, Inc. (NASDAQ:OCUP – Get Rating) – Equities researchers at HC Wainwright issued their Q1 2023 earnings per share estimates for shares of Ocuphire Pharma in a note issued to investors on Friday, March 31st. HC Wainwright analyst M. Caufield expects that the company will post earnings of ($0.24) per share for the quarter. […]
Alanr Meyer Mina Patel Soouch Ocuphire Pharma Richmond Brothers Inc Ocuphire Pharma Company Profile Ocuphire Pharma Inc

Ocuphire Pharma (NASDAQ:OCUP) Receives Buy Rating from HC Wainwright

HC Wainwright reissued their buy rating on shares of Ocuphire Pharma (NASDAQ:OCUP – Get Rating) in a research note issued to investors on Friday morning, Benzinga reports. They currently have a $20.00 price target on the stock. HC Wainwright also issued estimates for Ocuphire Pharma’s Q1 2023 earnings at ($0.24) EPS, Q2 2023 earnings at […]
Ocuphire Pharma Mina Patel Soouch Alanr Meyer Bedel Financial Consulting Inc Kestra Private Wealth Services Ocuphire Pharma Inc

Analysts Offer Predictions for Ocuphire Pharma, Inc.'s Q1 2023 Earnings (NASDAQ:OCUP)

Ocuphire Pharma, Inc. (NASDAQ:OCUP – Get Rating) – Analysts at HC Wainwright issued their Q1 2023 earnings per share (EPS) estimates for shares of Ocuphire Pharma in a report issued on Friday, March 31st. HC Wainwright analyst M. Caufield anticipates that the company will earn ($0.24) per share for the quarter. HC Wainwright currently has […]
Russia General Mina Patel Soouch Ocuphire Pharma Alanr Meyer Lincoln National Corp Ocuphire Pharma Inc

Ocuphire Pharma (NASDAQ:OCUP) Earns "Buy" Rating from HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Ocuphire Pharma (NASDAQ:OCUP – Get Rating) in a report released on Friday, Benzinga reports. HC Wainwright currently has a $20.00 price target on the stock. HC Wainwright also issued estimates for Ocuphire Pharma’s Q1 2023 earnings at ($0.24) EPS, Q2 2023 earnings at ($0.27) EPS, Q3 […]
Mina Patel Soouch Ocuphire Pharma Alanr Meyer Renaissance Technologies Kestra Private Wealth Services Ocuphire Pharma Company Profile

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science